Compare Novartis with - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NOVARTIS vs PANACHE INNOVATIONS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    NOVARTIS PANACHE INNOVATIONS NOVARTIS/
PANACHE INNOVATIONS
 
P/E (TTM) x 88.4 -168.6 - View Chart
P/BV x 2.8 3.4 83.6% View Chart
Dividend Yield % 1.2 0.0 -  

Financials

 NOVARTIS   PANACHE INNOVATIONS
EQUITY SHARE DATA
    NOVARTIS
Mar-21
PANACHE INNOVATIONS
Mar-20
NOVARTIS/
PANACHE INNOVATIONS
5-Yr Chart
Click to enlarge
High Rs77043 1,788.6%   
Low Rs50121 2,414.5%   
Sales per share (Unadj.) Rs154.534.5 448.3%  
Earnings per share (Unadj.) Rs8.50.4 2,293.9%  
Cash flow per share (Unadj.) Rs13.40.4 3,212.1%  
Dividends per share (Unadj.) Rs10.000-  
Avg Dividend yield %1.60-  
Book value per share (Unadj.) Rs289.27.9 3,682.6%  
Shares outstanding (eoy) m24.694.39 562.4%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x4.10.9 444.4%   
Avg P/E ratio x75.186.3 87.0%  
P/CF ratio (eoy) x47.576.5 62.0%  
Price / Book Value ratio x2.24.1 54.1%  
Dividend payout %118.10-   
Avg Mkt Cap Rs m15,691140 11,204.7%   
No. of employees `000NANA-   
Total wages/salary Rs m1,08511 9,543.5%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,814151 2,521.5%  
Other income Rs m3323 10,473.2%   
Total revenues Rs m4,146154 2,684.6%   
Gross profit Rs m267-1 -50,339.6%  
Depreciation Rs m1220 57,904.8%   
Interest Rs m771 7,529.4%   
Profit before tax Rs m4001 28,197.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1910 -91,142.9%   
Profit after tax Rs m2092 12,901.2%  
Gross profit margin %7.0-0.4 -1,991.9%  
Effective tax rate %47.8-14.5 -330.6%   
Net profit margin %5.51.1 510.9%  
BALANCE SHEET DATA
Current assets Rs m9,224131 7,054.8%   
Current liabilities Rs m3,57397 3,671.0%   
Net working cap to sales %148.222.1 670.5%  
Current ratio x2.61.3 192.2%  
Inventory Days Days1760 44,085.4%  
Debtors Days Days37159 23.2%  
Net fixed assets Rs m2,4801 370,119.4%   
Share capital Rs m12344 281.1%   
"Free" reserves Rs m7,018-9 -74,501.1%   
Net worth Rs m7,14134 20,711.7%   
Long term debt Rs m00-   
Total assets Rs m11,703131 8,905.9%  
Interest coverage x6.22.4 260.8%   
Debt to equity ratio x00-  
Sales to assets ratio x0.31.2 28.3%   
Return on assets %2.42.0 121.5%  
Return on equity %2.94.7 62.2%  
Return on capital %6.77.1 94.6%  
Exports to sales %9.30-   
Imports to sales %00-   
Exports (fob) Rs m354NA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m3540-   
Fx outflow Rs m9740-   
Net fx Rs m-6210-   
CASH FLOW
From Operations Rs m-692-11 6,332.1%  
From Investments Rs m952-7 -13,672.4%  
From Financial Activity Rs m-368-1 72,156.9%  
Net Cashflow Rs m-109-18 590.0%  

Share Holding

Indian Promoters % 0.0 30.8 -  
Foreign collaborators % 70.7 0.0 -  
Indian inst/Mut Fund % 1.2 0.0 -  
FIIs % 0.0 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 29.3 69.3 42.3%  
Shareholders   39,488 739 5,343.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare NOVARTIS With:   OMNITEX IND.  MRC EXIM   BLUE PEARL TEXSPIN  REMEDIUM LIFECARE  MISHKA EXIM  



Today's Market

Sensex Opens Flat; Tata Motors & NTPC Top Gainers(09:30 am)

Asian stock markets opened lower today as investors tried to digest the crisis at Chinese property giant Evergrande. Markets in Korea and Hong Kong were shut.

Related Views on News

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

NOVARTIS Announces Quarterly Results (3QFY20); Net Profit Down 39.9% (Quarterly Result Update)

Feb 17, 2020 | Updated on Feb 17, 2020

For the quarter ended December 2019, NOVARTIS has posted a net profit of Rs 77 m (down 39.9% YoY). Sales on the other hand came in at Rs 1 bn (down 13.4% YoY). Read on for a complete analysis of NOVARTIS's quarterly results.

More Views on News

Most Popular

5 Indian Companies that are Leading the AI Race(Views On News)

Sep 9, 2021

During the pandemic, India reported the highest increase in the use of AI at 45% compared to other major economies. AI has potential to add US$90 bn to the Indian economy by 2025.

5 Specialty Chemical Stocks that Turned Multibaggers in One Year(Views On News)

Sep 17, 2021

These specialty chemical stocks have surged 200% or more in the last year. Do you own any?

How to Create a Second Income from Trading(Profit Hunter)

Sep 10, 2021

My trading system that works in all kinds of markets.

A Rare Buying Opportunity in an Exciting Stock(Profit Hunter)

Sep 16, 2021

Whether agriculture sector goes through a structural transformation or not, this agrochemical stock has a good chance of winning.

5 Indian Companies with Over 7% in Dividend Yield(Views On News)

Sep 17, 2021

These stocks will give you better yields than bank deposits.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2021
Get our special report Multibagger Stocks Guide (2021 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

NOVARTIS SHARE PRICE


Sep 22, 2021 11:39 AM

TRACK NOVARTIS

  • Track your investment in NOVARTIS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

NOVARTIS 8-QTR ANALYSIS

COMPARE NOVARTIS WITH

MARKET STATS